Cargando…

Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma

BACKGROUND: Prostatic carcinoma is the second most common cause of cancer-related deaths in males in the West. Approximately 20% of patients present with metastatic disease. We describe the case of a patient with metastatic prostate cancer to the bowel presenting clinically and radiologically as a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabeer, Muhammad A, Lloyd-Davies, Edward, Maskell, Giles, Hohle, Rolf, Mathew, Joseph
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779271/
https://www.ncbi.nlm.nih.gov/pubmed/17207288
http://dx.doi.org/10.1186/1477-7819-5-2
_version_ 1782131739657764864
author Kabeer, Muhammad A
Lloyd-Davies, Edward
Maskell, Giles
Hohle, Rolf
Mathew, Joseph
author_facet Kabeer, Muhammad A
Lloyd-Davies, Edward
Maskell, Giles
Hohle, Rolf
Mathew, Joseph
author_sort Kabeer, Muhammad A
collection PubMed
description BACKGROUND: Prostatic carcinoma is the second most common cause of cancer-related deaths in males in the West. Approximately 20% of patients present with metastatic disease. We describe the case of a patient with metastatic prostate cancer to the bowel presenting clinically and radiologically as a primary caecal cancer. CASE PRESENTATION: A 72 year-old man presented with abdominal discomfort and a clinically palpable caecal mass and a firm nodule on his thigh, the latter behaving clinically and radiologically as a lipoma. Computed tomographic (CT) scan showed a luminally protuberant caecal mass with regional nodal involvement. The patient was being treated (Zoladex(®)) for prostatic cancer diagnosed 6 years previously and was known to have bony metastases. On admission his PSA was 245.4 nmol/ml. The patient underwent a right hemicolectomy. Histology showed a poorly differentiated adenocarcinoma which was PSA positive, confirming metastatic prostatic adenocarcinoma to the caecum. The patient underwent adjuvant chemotherapy and is free from recurrence a year later. CONCLUSION: Metastasis of prostatic carcinoma to the bowel is a very rare occurrence and presents a challenging diagnosis. The diagnosis is supported by immunohistochemistry for PSA. The treatment for metastatic prostate cancer is mainly palliative.
format Text
id pubmed-1779271
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17792712007-01-20 Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma Kabeer, Muhammad A Lloyd-Davies, Edward Maskell, Giles Hohle, Rolf Mathew, Joseph World J Surg Oncol Case Report BACKGROUND: Prostatic carcinoma is the second most common cause of cancer-related deaths in males in the West. Approximately 20% of patients present with metastatic disease. We describe the case of a patient with metastatic prostate cancer to the bowel presenting clinically and radiologically as a primary caecal cancer. CASE PRESENTATION: A 72 year-old man presented with abdominal discomfort and a clinically palpable caecal mass and a firm nodule on his thigh, the latter behaving clinically and radiologically as a lipoma. Computed tomographic (CT) scan showed a luminally protuberant caecal mass with regional nodal involvement. The patient was being treated (Zoladex(®)) for prostatic cancer diagnosed 6 years previously and was known to have bony metastases. On admission his PSA was 245.4 nmol/ml. The patient underwent a right hemicolectomy. Histology showed a poorly differentiated adenocarcinoma which was PSA positive, confirming metastatic prostatic adenocarcinoma to the caecum. The patient underwent adjuvant chemotherapy and is free from recurrence a year later. CONCLUSION: Metastasis of prostatic carcinoma to the bowel is a very rare occurrence and presents a challenging diagnosis. The diagnosis is supported by immunohistochemistry for PSA. The treatment for metastatic prostate cancer is mainly palliative. BioMed Central 2007-01-07 /pmc/articles/PMC1779271/ /pubmed/17207288 http://dx.doi.org/10.1186/1477-7819-5-2 Text en Copyright © 2007 Kabeer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kabeer, Muhammad A
Lloyd-Davies, Edward
Maskell, Giles
Hohle, Rolf
Mathew, Joseph
Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma
title Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma
title_full Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma
title_fullStr Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma
title_full_unstemmed Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma
title_short Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma
title_sort metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779271/
https://www.ncbi.nlm.nih.gov/pubmed/17207288
http://dx.doi.org/10.1186/1477-7819-5-2
work_keys_str_mv AT kabeermuhammada metastaticprostatecancermasqueradingclinicallyandradiologicallyasaprimarycaecalcarcinoma
AT lloyddaviesedward metastaticprostatecancermasqueradingclinicallyandradiologicallyasaprimarycaecalcarcinoma
AT maskellgiles metastaticprostatecancermasqueradingclinicallyandradiologicallyasaprimarycaecalcarcinoma
AT hohlerolf metastaticprostatecancermasqueradingclinicallyandradiologicallyasaprimarycaecalcarcinoma
AT mathewjoseph metastaticprostatecancermasqueradingclinicallyandradiologicallyasaprimarycaecalcarcinoma